Re‐evaluating age‐related attention‐deficit/hyperactivity disorder (ADHD) symptom trajectories using the Japanese ADHD Rating Scale‐5

Abstract Aim Attention‐deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by inattention (IA), hyperactivity, and impulsivity. In 2022, the Japanese version of the ADHD Rating Scale‐5 (ADHD‐RS‐5) was released based on DSM‐5. Although there are several changes compar...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Ryotaro Shimomura, Yukie Tateno, Keisuke Oyatani, Kotaro Nanba, Eri Shiraishi, Masaru Tateno
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Wiley 2026-03-01
Reeks:	PCN Reports
Onderwerpen:	attention‐deficit/hyperactivity disorder functional impairment medication neurodevelopmental disorder pharmacotherapy rating scale
Online toegang:	https://doi.org/10.1002/pcn5.70301
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!